Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Edward C. Senay"'
Autor:
James A. Inciardi, Anne Geller, Edgar H. Adams, Edward C. Senay, Alvaro Muñoz, George E. Woody, Theodore J. Cicero
Publikováno v:
Journal of Addictive Diseases. 25:53-58
Ultram (tramadol HCL) was approved by the Food and Drug Administration in 1994 as a non-scheduled drug under the Controlled Substance Act. The non-scheduled status was contingent on the development and implementation of a comprehensive post-marketing
Autor:
Sidney H. Schnoll, Edgar H. Adams, Scott Breiner, James A. Inciardi, Theodore J. Cicero, Anne Geller, George E. Woody, Edward C. Senay
Publikováno v:
Journal of Pain and Symptom Management. 31:465-476
Concern about abuse/dependence in chronic pain patients taking opioid analgesics may lead to undertreatment of pain, yet little is known about the prevalence of abuse/dependence in these patients and how it differs among analgesic agents. The objecti
Autor:
James A. Inciardi, Alvaro Muñoz, Edward C. Senay, Sidney H. Schnoll, Theodore J. Cicero, Edgar H. Adams, Anne Geller, George E. Woody
Publikováno v:
Drug and Alcohol Dependence. 72:163-168
Objective: Assess the validity of medical products reporting program (MEDWatch) reports of abuse/dependence and withdrawal associated with Ultram (tramadol). Methods: Reports of possible abuse/dependence or withdrawal associated with Ultram during 13
Autor:
James A. Inciardi, Theodore J. Cicero, Sidney H. Schnoll, George E. Woody, Alvaro Muñoz, Edgar H. Adams, Anne Geller, Edward C. Senay
Publikováno v:
Drug and Alcohol Dependence. 57:7-22
Tramadol HCl, marketed as Ultram in the USA, was introduced as a non-scheduled drug in April 1995 based on the assumption that the risk of abuse was sufficiently low to warrant a non-scheduled status. However, approval was contingent upon the develop
Publikováno v:
Journal of Drug Issues. 27:329-340
The effectiveness of a case management model in improving treatment access, retention, and outcomes was examined within a cohort of 360 intravenous drug users (IDUs) pursuing substance-abuse treatment through a central intake facility. IDUs were rand
Autor:
Edward C. Senay
Publikováno v:
Advances in Alcohol & Substance Abuse. 9:53-64
This paper examines data on the question of possible differences between benzodiazepines in abuse liability and potential for causing physical dependence. The data on potential for causing physical dependence indicates that all benzodiazepines cause
Autor:
Edward C. Senay, Alice Hughes, Meredith Y. Smith, George E. Woody, Salvatore V. Colucci, Richard C. Dart, Anne Geller
Publikováno v:
The American journal of drug and alcohol abuse. 32(3)
Poison Control Center (PCC) cases involving intentional ingestion, injection or inhalation of prescription opioids are a potentially valuable source of information on the abuse and misuse of these products. This study sought to validate PCC classific
Autor:
Anne Geller, Edward C. Senay, Edgar H. Adams, Alvaro Muñoz, Theodore J. Cicero, James A. Inciardi, George E. Woody
Publikováno v:
Pharmacoepidemiology and drug safety. 14(12)
Purpose The analgesic Tramadol HCl (Ultram™) was approved in 1994 as a non-scheduled drug under the CSA provided that a novel risk-management program would be developed by an Independent Steering Committee (ISC). The risk-management program began i
Autor:
Edward C. Senay, Anne Geller, Theodore J. Cicero, George E. Woody, James A. Inciardi, Sidney H. Schnoll, Alvaro Muñoz, Edgar H. Adams
Publikováno v:
Drug and alcohol dependence. 69(3)
In 1994, the Drug Abuse Advisory Committee (DAAC) of the Food and Drug Administration (FDA) concluded that Ultram® (tramadol hydrochloride) could be marketed as an analgesic drug without scheduling under the Controlled Substances Act based upon exte
Autor:
Edward C. Senay, Lynn R. Boyle
Publikováno v:
AIDS Patient Care. 5:301-303